Mechanisms for GroEL/GroES-mediated Folding of a Large 86-kDa Fusion Polypeptide in Vitro*

Yi-Shuian HuangDagger and David T. Chuang§

From the Department of Biochemistry and the Biochemistry and Molecular Biology Graduate Program, University of Texas Southwestern Medical Center, Dallas, Texas 75235

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Our understanding of mechanisms for GroEL/GroES-assisted protein folding to date has been derived mostly from studies with small proteins. Little is known concerning the interaction of these chaperonins with large multidomain polypeptides during folding. In the present study, we investigated chaperonin-dependent folding of a large 86-kDa fusion polypeptide, in which the mature maltose-binding protein (MBP) sequence was linked to the N terminus of the alpha  subunit of the decarboxylase (E1) component of the human mitochondrial branched-chain alpha -ketoacid dehydrogenase complex. The fusion polypeptide, MBP-alpha , when co-expressed with the beta  subunit of E1, produced a chimeric protein MBP-E1 with an (MBP-alpha )2beta 2 structure, similar to the alpha 2beta 2 structure in native E1. Reactivation of MBP-E1 denatured in 8 M urea was absolutely dependent on GroEL/GroES and Mg2+-ATP, and exhibited strikingly slow kinetics with a rate constant of 376 M-1 s-1, analogous to denatured untagged E1. Chaperonin-mediated refolding of the MBP-alpha fusion polypeptide showed that the folding of the MBP moiety was about 7-fold faster than that of the alpha  moiety on the same chain with rate constants of 1.9 × 10-3 s-1 and 2.95 × 10-4 s-1, respectively. This explained the occurrence of an MBP-alpha ·GroEL binary complex that was isolated with amylose resin from the refolding mixture and transformed Escherichia coli lysates. The data support the thesis that distinct functional sequences in a large polypeptide exhibit different folding characteristics on the same GroEL scaffold. Moreover, we show that when the alpha ·GroEL complex (molar ratio 1:1) was incubated with GroES, the latter was capable of capping either the very ring that harbored the 48-kDa (His)6-alpha polypeptide (in cis) or the opposite unoccupied cavity (in trans). In contrast, the MBP-alpha ·GroEL (1:1) complex was capped by GroES exclusively in the trans configuration. These findings suggest that the productive folding of a large multidomain polypeptide can only occur in the GroEL cavity that is not sequestered by GroES.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Molecular chaperones are a class of proteins which assist folding of other proteins in the cell by preventing or reversing aggregation caused by off-pathway folding reactions (1-3). Many of the chaperones are heat shock proteins (Hsp),1 named for their induced synthesis in cells during heat-shock stress. Group I chaperonins (4, 5) include GroEL/GroES in bacteria, Hsp60/Hsp10 in eukaryotic mitochondria, and ribulose-P2 carboxylase-binding protein/cpn21 in plant chloroplasts (6, 7). These proteins exhibit remarkable structural and functional conservation from bacteria to plants to humans (8-10). The conserved function in the chaperonin family is the basis that bacterial GroEL and GroES are widely used in promoting refolding of various proteins, including those from mitochondria and chloroplasts both in vitro and in Escherichia coli (1-3). The biogenesis of eukaryotic mitochondrial matrix proteins is proposed to follow a complex chaperone-mediated pathway (11-13). Unfolded subunit polypeptides are imported into mitochondria as aided by Hsp70 family chaperones, and the final stage of folding and assembly of mitochondrial oligomeric proteins is promoted by chaperonins Hsp60/Hsp10 (11-13).

Our laboratory has previously shown the obligatory role of GroEL and GroES in facilitating folding and assembly of the decarboxylase (E1) and the transacylase (E2) components of human branched-chain alpha -ketoacid dehydrogenase complex in vitro (14, 15) and in E. coli (16). E1 is a thiamine pyrophosphate-dependent enzyme, consisting of two 45-kDa alpha  and two 38-kDa beta  subunits (17). In an earlier study (18), we overexpressed MBP-E1 in which the mature sequence of maltose-binding protein (MBP) was fused to the N terminus of the mature alpha  subunit (abbreviated MBP-alpha ). Although MBP was shown to rapidly and efficiently refold in vitro without chaperonins (18), the overexpression of MBP-E1 in E. coli required co-expression of GroEL/GroES (16, 19). The results have established that fusion of a spontaneously refolded protein to the alpha  sequence from E1 does not change chaperonin-dependent folding characteristics of the latter sequence.

The native conformation of a large polypeptide is often folded into several compact regions or domains (20). Previous studies with spontaneously refolded proteins, e.g. tryptophan synthetase (21, 22), dihydrofolate reductase (23), and aspartokinase-homoserine-dehydrogenase (24, 25), show that individual domains in the entire polypeptide chain refold differentially and can be expressed as soluble functional units, suggesting that the domain alone is a folding unit. Co-translational independent domain folding in eukaryotes has been recently demonstrated using a Ras-dihydrofolate reductase fusion polypeptide (26). Molecular chaperones do not contain information for specifying correct folding. The information for folding into the functional three-dimensional structure of a protein is solely present in its amino acid sequence (27). Thus, one can reasonably expect that independent domain folding also occurs on the GroEL scaffold.

The crystal structure of unliganded GroEL double-ring complex has indicated that, in the absence of GroES, a polypeptide of up to ~35 kDa in size can be accommodated within a single ring of GroEL (28, 29). Binding of GroES, however, induces a large conformational change in GroEL, leading to an approximate doubling of the volume in the central cavity of that ring. This allows the accommodation of polypeptides of ~70 kDa in size (30). Because of the size constraint of the GroEL cavity, it has been proposed that GroES promotes the productive release of polypeptides larger than 70 kDa from a trans configuration, in which GroES and the unfolded polypeptide bind to the opposite rings of GroEL (31). However, evidence for the productive trans release of large polypeptides from GroEL is lacking.

In the present study, we investigate GroEL/GroES-assisted refolding of the large 86-kDa MBP-alpha fusion polypeptide in vitro. The kinetic data show that the MBP moiety folds appreciably more rapidly than the alpha  subunit. This explains the isolation of an MBP-alpha ·GroEL binary complex from the MBP-E1 refolding mixture and E. coli lysates with amylose resin. Moreover, we provide evidence that GroES can only cap the MBP-alpha ·GroEL complex in trans in relation to the fusion polypeptide. This is in contrast to that observed in the alpha ·GroEL complex where GroES binds to GroEL in both cis and trans configurations. These findings provide a paradigm for independent domain folding during chaperonin-assisted folding of large multidomain polypeptides.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- CG712 (an E. coli ESts strain) and the expression plasmid pGroESL overexpressing GroEL and GroES (32) were generous gifts from Drs. George Lorimer and Anthony Gatenby of DuPont Experimental Station (Wilmington, DE). The pH1 plasmid carrying MBP-alpha and -beta sequences, the pHisT-hE1 plasmid harboring (His)6-alpha and -beta sequences, and the pMAL-c-hE1alpha plasmid carrying MBP-alpha sequence were previously described (19, 33). The MBP or (His)6 tag was fused to the N terminus of the mature alpha  sequence through a linker containing the factor Xa or tobacco etch virus protease-specific site, respectively. GroEL and GroES were overexpressed in E. coli and purified as described previously (14). Amylose resin was prepared according to a previously reported method (34).

Expression and Purification of MBP-E1, MBP-alpha , and E1-- CG-712 cells co-transformed with pGroESL and the pH1, pMAL-c-hE1alpha , or pHisT-hE1 plasmids were grown overnight at 37 °C in YTGK media containing 2 × YT medium (35), 10 mM KCl, 1% glycerol, and antibiotics (100 µg/ml ampicillin and 50 µg/ml chloramphenicol). The overnight culture was diluted 6:1000 into 1 liter of YTGK medium with added antibiotics. Cultures were grown on a shaker at 220 rpm and 37 °C to a measured A600 of 0.6, and expression was induced with 0.75 mM isopropyl-1-thio-beta -D-galactosidase. After induction, cultures were grown at 37 °C for 16 h. The extraction of MBP-E1 and MBP-alpha from the E. coli lysate with amylose resin was described previously (19). The purified proteins were separated on a 10-30% sucrose density gradient. Purification of (His)6-E1 on the Ni-NTA column was also previously described (33). To prepare untagged E1, dialyzed (His)6-E1 was digested with the tobacco etch virus protease. Undigested (His)6-E1 was removed by Ni-NTA extraction.

GroEL/GroES-assisted and Spontaneous Refolding of Substrate Proteins-- MBP-E1, E1, or MBP was incubated for 1 h at 22 °C in a denaturing buffer (50 mM potassium Pi, pH 7.5, 100 mM KCl, 8 M urea, 0.1% Tween 20, and 1 mM dithiothreitol). Refolding was initiated at 22 °C by a 100-fold dilution of the denatured protein into a refolding buffer (50 mM potassium Pi, pH 7.5, 100 mM KCl, 1 mM thiamine pyrophosphate, 5 mM dithiothreitol, and 5 mM MgCl2) containing GroEL/GroES (molar ratio of GroEL:GroES:monomeric substrate = 2:4:1). Unless otherwise specified, the final concentration of the denatured monomer was 0.5 µM. Rapid mixing was accomplished by vortexing of a denatured protein drop into the refolding buffer, which was immediately followed by an addition of 10 mM ATP. At indicated times, an aliquot of 50 µl was withdrawn and frozen at -20 °C until assays for E1 activity. E1 activity was assayed radiochemically in a reconstituted branched-chain alpha -ketoacid dehydrogenase system with the addition of excess recombinant E2 and E3 components as described elsewhere (14). An identical concentration of nondenatured E1 or MBP-E1 was also added into the separate refolding buffer and incubated at 22 °C to serve as the 100% activity control. The folding efficiency was defined as the percent recovery of activity compared with the 100% activity control at the final time point.

Amylose Resin Extraction and Analysis by Sucrose Density Gradient Centrifugation-- Unless otherwise stated, at indicated times, aliquots (1 ml) of the refolding mixture was withdrawn, and the refolding reaction was terminated by the addition of 50 mM CDTA to chelate Mg2+ ions. The refolding mixture was incubated with 0.5 ml of amylose resin for 10 min. After a brief spinning, the supernatant was removed and the resin was washed three times with 1 ml of the refolding buffer. Proteins bound to the resin were eluted twice with 0.5 ml of the refolding buffer containing 20 mM maltose. The eluted protein sample was loaded on a 10-30% sucrose density gradient, and separated by centrifugation at 210,000 × g for 18 h.

Determination of Rate Constants for the E1 Refolding Reaction (36, 37)-- To determine rate constants for the folding of MBP and alpha  moieties, the data were fit to the first-order rate equation: ln[A] = ln[A]0-kt, where [A] = molar concentration of the reactant, i.e. the MBP or the alpha  moiety at a given time; [A]0 = initial concentration of the reactant; k = rate constant for the folding reaction, and t = the reaction time. To determine rate constants for the reconstitution of E1 activity from denatured E1 or MBP-E1, the data were fit to second-order rate equation kt = 1/[A- 1/[A]0, where [A] = alpha , MBP-alpha or -beta monomers at a given time. The percent of E1 activity recovered was used to calculate the amount of E1 or MBP-E1 tetramers formed. The same amount of E1 or MBP-E1 not treated with the denaturant was incubated in the refolding buffer for 24 h, and the enzyme activity served as a 100% refolding control. The percent of folded E1 or MBP-E1 tetramers at different time points was calculated. The concentration of remaining E1 monomers was derived by subtracting a 2-fold concentration of the E1 tetramer formed from the initial concentration of the monomer (alpha , MBP-alpha or -beta ). The assumption was that the alpha  and beta  subunits participating in the E1 refolding reaction either stayed as monomers or complexed with each other to form heterodimers or heterotetramers according to the assembly pathway: 2 alpha  + 2 beta  right-arrow 2 alpha beta right-arrow alpha 2beta 2 (14). The concentrations of alpha  and beta  monomers were identical at any time during the refolding. Therefore, V = k [alpha ][beta ] was treated as V = k[alpha ]2 = k[beta ]2, where V = velocity. The second-order equation, kt = 1/[alpha - 1/[alpha ]0 = 1/[beta - 1/[beta ]0 was derived after integration.

Proteinase K Digestion of Folding Intermediates-- At indicated times of the refolding reaction, a 100-µl aliquot of the refolding mixture containing 0.5 µM MBP was removed. The sample was digested with 4 µg/ml PK for 10 min at 22 °C, and the digestion then quenched with 5 mM PMSF. The same amounts of native MBP-E1 and MBP were also treated with PK and served as a 100% refolding control. The protease-digested samples were precipitated with 7.5% trichloroacetic acid containing 125 µg/ml sodium deoxycholate, and analyzed by SDS-PAGE and Western blotting.

Preparation of MBP-alpha ·GroEL, (His)6-alpha ·GroEL, and beta ·GroEL Complexes-- MBP-E1 (3 mg) was denatured in 400 µl of the denaturation buffer (50 mM sodium acetate, pH 4.5, and 8 M urea) for 15 min. The denatured protein was incubated with 200 µl of the carboxymethyl-Sepharose CL-6B resin (Pharmacia) equilibrated with the denaturation buffer for 15 min. The resin was washed with the denaturation buffer containing 60 mM KCl. Denatured MBP-alpha bound to the resin was eluted with the denaturation buffer containing 300 mM KCl. The eluted MBP-alpha was repeatedly diluted in 50 mM potassium Pi, pH 7.5, containing 100 mM KCl and 8 M urea and concentrated in a Microcon-30 concentrator (Amicon). The denatured protein was diluted into 50 mM potassium Pi, pH 7.5, containing 100 mM KCl and 1:1 molar ratio of GroEL to make 1:1 stoichiometric substrate-GroEL complexes. The mixture was separated on a 10-25% sucrose density gradient and the MBP-alpha ·GroEL complex collected. The preparation of (His)6-alpha ·GroEL and beta ·GroEL complexes was described (14).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Kinetic Measurements for Renaturation of E1 and MBP-E1-- The refolding of untagged E1 or MBP-E1 denatured in 8 M urea was initiated by dilution of the denatured protein into a refolding buffer at 22 °C containing GroEL/GroES and Mg2+-ATP. Fig. 1 shows the time course for reactivation of untagged E1. No E1 activity was recovered when GroEL, GroES, or Mg2+-ATP was omitted from the refolding mixture. The folding kinetics of E1 at concentrations of 0.125 µM and 0.0625 µM were fit to the second-order equation, with rate constants of 512 and 417 M-1 s-1, respectively. The folding of MBP-E1 also showed an absolute requirement for GroEL/GroES and Mg2+-ATP (Fig. 2). The kinetic data at 0.2, 0.1, and 0.05 µM denatured MBP-E1 were fit to the second-order equation. This resulted in rate constants of 324, 397, and 407 M-1 s-1, respectively, for the reactivation of E1 activity. The average rate constant for untagged E1 was 465 M-1 s-1 and for MBP-E1 was 376 M-1 s-1.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Kinetics for GroEL/GroES-dependent reconstitution of untagged human E1. Recombinant human E1 was denatured in 8 M urea and reconstituted at 22 °C in the presence of GroEL/GroES and Mg2+-ATP as described under "Experimental Procedures." The final concentrations of denatured E1 tetramers for refolding, following a 100-fold dilution, were 0.25 µM (), 0.125 µM (diamond ), and 0.0625 µM (open circle ). The data at 0.125 and 0.0625 µM of E1 were fit to the second-order function to yield rate constants. Folding efficiencies at 0.25, 0.125, and 0.0625 µM denatured E1 were 68, 60, and 83%, respectively. Delta , GroEL, GroES, or Mg2+-ATP omitted. One milliunit (mU) was defined as 1 nmol of 14CO2 evolved per min.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2.   Time course for chaperonin-mediated reactivation of urea-denatured MBP-E1. The denaturation and reconstitution at 22 °C of the MBP-E1 fusion protein were as described in the legend to Fig. 1. The concentrations of the denatured MBP-E1 tetramer for refolding were 0.2 µM (), 0.1 µM (diamond ), and 0.05 µM (open circle ). The data at all three protein concentrations were fit to the second-order function to produce folding rate constants. Folding efficiencies at 0.2, 0.1, and 0.05 µM denatured MBP-E1 were 67, 99, and 84%, respectively. Delta , GroEL, GroES, or Mg2+-ATP absent.

Folded State of Fused and Unfused Maltose-binding Protein-- The urea-denatured MBP was refolded for 1 h at 22 °C in the absence or presence of GroEL·GroES·Mg2+-ATP. The refolded MBP was digested with PK (4 µg/ml) and separated on a sucrose density gradient, and the fractions were analyzed by SDS-PAGE. The appearance of MBP on the top of the sucrose density gradient either without (panel A) or with (panel B) chaperonins indicated that the refolded MBP was soluble and resistant to PK digestion (Fig. 3). The results showed that limited proteolysis with PK was a feasible approach to monitor MBP refolding. The GroEL 14-mer sedimented to the bottom of the gradient (panel B). The presence of GroEL monomers at the top of the gradient resulted from a partial dissociation of the GroEL 14-mer during centrifugation in the presence of Mg2+-ATP (38).


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 3.   Resistance of refolded MBP to proteinase K digestion. MBP denatured in 8 M urea was diluted into the refolding buffer (final concentration 0.5 µM) and refolded for 1 h at 22 °C in the absence (panel A) or presence (panel B) of GroEL/GroES/Mg2+-ATP. The refolding mixture was subsequently treated with 4 µg/ml PK also at 22 °C for 10 min and the digestion quenched with PMSF. The digested MBP refolding mixture (100 µl in panel A and 240 µl in panel B) was separated on a 10-25% sucrose density gradient and fractions analyzed on 12% SDS gels, followed by Coomassie Blue staining.

The refolding kinetics of unfused and fused forms of MBP denatured in 8 M urea was studied. Aliquots taken at different times during the refolding at 22 °C were treated with PK, followed by analysis by SDS-PAGE. To increase sensitivity of the folding assay, the PK-resistant MBP moiety was probed with the antibody to MBP by Western blotting. Radioactivity associated with the PK-resistant folded MBP moiety was compared with the intensity of the PK-treated native MBP or MBP-E1 control present at the same level as that used in the refolding reaction. Either control was expressed as 100% folded MBP. As shown in Fig. 4, refolding of unconjugated MBP reached 99.8 and 99.5% of the native MBP control in the absence or presence of GroEL·GroES·Mg2+-ATP, respectively. The plateau levels for refolding of the MBP moiety on the MBP-alpha fusion polypeptide from the denatured MBP-E1 were 68.3 and 27.2% in the presence or absence of GroEL·GroES·Mg2+-ATP, respectively (Fig. 4). The rate constants for the first-order reaction for MBP folding in the absence or presence of chaperonins were 0.020 and 0.036 s-1, respectively. They were in the same order of magnitude as previously reported value of 0.025 s-1 for spontaneous MBP refolding (39), as determined by tryptophan fluorescence measurements. The rate constants for refolding of the MBP moiety on MBP-alpha in the absence or presence of chaperonins are 1.1 × 10-3 and 1.9 × 10-3 s-1, respectively (Fig. 4). These values are an order of magnitude lower than those measured with unlinked MBP.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Folding kinetics of unfused and fused forms of MBP in the presence or absence of GroEL/GroES. The urea-denatured MBP or MBP-E1 was refolded at 0.25 and 0.125 µM, respectively, at 22 °C with or without GroEL/GroES/Mg2+-ATP. At different times, aliquots were withdrawn and digested with 4 µg/ml PK at 22 °C for 10 min. The same amount of native MBP or MBP-E1 treated with PK was used as a control (100% standard). After quenching with PMSF, the digested mixture was separated on SDS-PAGE, transferred to Immobilon-P membrane (Millipore), and probed with the MBP antibody and 125I-protein A. The radioactivity associated with protein bands was quantified by PhosphorImaging. , unfused MBP without chaperonins; diamond , unfused MBP with GroEL/GroES/Mg2+-ATP; Delta , MBP moiety in MBP-alpha fusion without chaperonins; open circle , MBP moiety in MBP-alpha fusion with GroEL/GroES/Mg2+-ATP.

Folded State of the alpha  Moiety during Renaturation of MBP-E1-- Since the folded alpha  subunit does not possess enzyme activity, the refolding of the alpha  moiety on MBP-alpha was monitored by the release of MBP-alpha monomers from GroEL and subsequent assembly of the folded alpha  moiety with beta  to form the (MBP-alpha )beta dimer or the (MBP-alpha )2beta 2 tetramer (14). Aliquots collected at different times during refolding were separated on a sucrose density gradient, and fractions analyzed by SDS-PAGE and Coomassie Blue staining. The reaction mixture was not extracted with amylose resin so that measurement of the released MBP-alpha fusion was not dependent on the prefolded MBP moiety. Fractions 3 to 8 corresponding to MBP-alpha monomers, (MBP-alpha )beta dimers, and (MBP-alpha )2beta 2 tetramers were quantified by densitometry scanning (Fig. 5A). As shown in Fig. 5A, at the 0-min time point, all of MBP-alpha or -beta was complexed with GroEL and sedimented close to the bottom of the gradient (fractions 13-15). The bands in fractions 3 and 4 were dissociated GroEL monomers. At the earlier time points (5 min to 1 h), the majority of MBP-alpha was present as unassembled MBP-alpha monomers (fractions 3 and 4) and assembled (MBP-alpha )beta dimers (fractions 4-6). At later time points (2 to 24 h), the dimers were gradually converted to (MBP-alpha )2beta 2 tetramers, which peaked in fractions 6-8. The identities of these E1 folding intermediates as separated by the sucrose density gradient were confirmed by fast protein liquid chromatography gel filtration (14).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   Kinetics of the alpha  moiety refolding on the MBP-alpha fusion polypeptide in the presence of GroEL/GroES. A, sedimentation profiles on a sucrose density gradient. The reconstitution of MBP-E1 denatured in 8 M urea was carried out as described under "Experimen-tal Procedures." Aliquots collected at different times without amylose resin extraction were separated on a 10-25% sucrose gradient, and fractions analyzed by SDS-PAGE, followed by Coomassie Blue staining. Due to space limitations, except for the 0-min point, only the MBP-alpha portion of the gel is shown. To normalize variations in Coomassie Blue staining, 1.5 µg of MBP-E1 was included in each gel (the Std. lane). The molecular mass markers (in kDa) used for calibration were: 40, MBP; 67, bovine serum albumin; 110, human E3; 158, aldolase; 232, catalase; 800, GroEL. B, the time course of folded MBP-alpha . The dye intensities of MBP-alpha bands in fractions 3-8 that contained MBP-alpha monomers, (MBP-alpha )beta dimers, and (MBP-alpha )2beta 2 tetramers were measured by densitometry and summed to represent folding of the alpha  moiety. The signal was linear with up to 10 µg of MBP-E1. The highest amount of MBP-alpha in combined fractions at the 4-h time point was expressed as 100%. C, time course for transition from dimers (fractions 4 and 5) () to tetramers (fractions 7 and 8) (open circle ) in panel A and the recovery of E1 activity (diamond ) from a separate experiment (Fig. 2, 0.1 µM) during the refolding.

The densities of all folded MBP-alpha species (fractions 3-8) were summed and the maximum at the 4-h time point was expressed as 100%. The percent of folded MBP-alpha species was plotted against the folding time to depict the refolding kinetics of the alpha  moiety. The folding of the alpha  moiety reached a plateau in about 4 h (Fig. 5B), which was much slower than the MBP (15 min) on the same fusion polypeptide (Fig. 4). The rate constant for folding of the alpha  moiety fit to the first-order reaction was 2.95 × 10-4 s-1. This rate constant is independent of assembly with the beta  subunit, since both unassembled and assembled MBP-alpha species were counted. To measure the percent formation of dimers and tetramers during the refolding, subtotals of the normalized MBP-alpha signal in fractions 4-5 (in the dimeric state) and fractions 7-8 (in the tetrameric state) were expressed as percents of the maximal intensity and plotted against the folding time (Fig. 5C). No significant E1 activity was recovered (about 10%) until 2 h when an appreciable amount of tetramers accumulated. The time course for recovery of E1 activity was in approximate parallel with that for the formation of MBP-E1 tetramers (Fig. 5C). The slight disconcordance between the two rates was the result of two separate experiments. The data show that the tetramer, but not the dimer, is the enzymatically active form, and confirm that the slow process in E1 refolding is the formation of tetramers from dimers (14).

An MBP-alpha ·GroEL Complex Isolated from the Transformed Bacterial Lysate-- During the overexpression of the MBP-alpha fusion polypeptide with GroEL·GroES in E. coli, a significant amount (10 mg/liter) of the MBP-alpha ·GroEL complex (Fig. 6, lanes 11-14) and aggregated MBP-alpha (Fig. 6, lane 15) were isolated with the amylose resin when analyzed by sucrose density gradient centrifugation. The data were consistent with the notion that the MBP moiety was folded and capable of binding to the resin. The alpha  moiety on the MBP-alpha fusion was apparently unfolded and associated with GroEL, resulting in the formation of the MBP-alpha ·GroEL complex. The MBP-alpha * polypeptide was a preterminated translation product. The MBP-alpha ·GroEL complex isolated from the E. coli lysate produced enzymatically active MBP-E1 when incubated with the beta ·GroEL complex and GroES·Mg2+-ATP (data not shown). The result indicated that the MBP-alpha ·GroEL complex was a productive folding intermediate when MBP-alpha was expressed in E. coli.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 6.   Isolation of the MBP-alpha ·GroEL complex with amylose resin from E. coli lysate in the absence of beta  expression. CG712 cells were co-transformed with the pMAL-c-hE1alpha and the pGroESL plasmids and the expression of MBP-alpha , GroEL, and GroES was induced by isopropyl-1-thio-beta -D-galactosidase. Cell lysates were extracted with amylose resin, and proteins eluted with 20 mM maltose were subsequently separated on a 10-30% sucrose density gradient. The bottom of the gradient (fraction 15) contained 2 M sucrose. MBP-alpha * was a preterminated translation product.

To ask whether the MBP-alpha /GroEL intermediate also occurred during MBP-E1 folding, aliquots collected from the refolding mixture were extracted with amylose resin and separated on a sucrose density gradient. As shown in Fig. 7, at the 10-min time point, when the majority of the MBP moiety was folded (Fig. 4) with a less than 50% maximum of the alpha  moiety folded or complexed with beta  (Fig. 5 B), a significant amount of the MBP-alpha ·GroEL complex was isolated with the resin (fractions 9-12) (Fig. 7, upper panel). At the 16-h time point, only (MBP-alpha )beta dimers (fractions 3 and 4) and (MBP-alpha )2beta 2 tetramers (fractions 5 and 6) were extracted with the resin (Fig. 7, lower panel). The data establish that the MBP-alpha ·GroEL complex is indeed a productive folding intermediate during the refolding of urea-denatured MBP-E1.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 7.   Isolation of the MBP-alpha /GroEL intermediate from the refolding mixture with amylose resin. Reconstitution of urea-denatured MBP-E1 was carried out at 22 °C in the presence of GroEL/GroES/Mg2+-ATP as described under "Experimental Procedures." At 10-min and 16-h points, aliquots (1 ml) of the MBP-E1 refolding reaction were incubated with 500 µl of amylose resin for 10 min at 22 °C. Proteins eluted with 20 mM maltose were separated on a 10-30% sucrose density gradient. Fractions were analyzed by SDS-PAGE and Coomassie Blue staining.

The trans-MBP-alpha ·GroEL Complex as a Folding Competent Species-- Due to the size constraint associated with the GroEL cavity, we suspected that during the folding reaction GroES can cap the MBP-alpha ·GroEL complex only at the open end unoccupied by the large 86-kDa fusion polypeptide, resulting in the exclusive trans configuration. To address this question, we first studied the binding of a smaller polypeptide 48-kDa (His)6-alpha to GroEL, and compared the results with those obtained with the larger MBP-alpha fusion. The 1:1 (His)6-alpha ·GroEL complex with only one ring of GroEL occupied by the small polypeptide was incubated with GroES without added nucleotides or in the presence of 10 mM ADP or ATP, followed by digestion with PK. The digestion was quenched with 5 mM PMSF, and to the mixture containing GroES and the digested (His)6-alpha ·GroEL complex, beta ·GroEL and 5 mM Mg2+-ATP were added to reconstitute E1 activity. As shown in Fig. 8A, in the absence of nucleotides and PK, the (His)6-alpha ·GroEL was intact and maintained the monomeric molar ratio of GroEL:(His)6-alpha  = 14:1 (lane 1). The undigested (His)6-alpha ·GroEL complex and GroES in the mixture, when incubated with beta ·GroEL and 5 mM Mg2+-ATP, resulted in a full recovery of E1 activity, which served as a 100% control (Fig. 8B, lane 1). In the presence of PK but absence of nucleotides, GroES was incapable of binding to GroEL. (His)6-alpha bound to GroEL was not protected and mostly digested (Fig. 8A, lane 2), which was consistent with the complete failure of the digested (His)6-alpha to reconstitute E1 activity with beta ·GroEL (Fig. 8B, lane 2). In the presence of GroES, ADP, and PK, GroES was able to cap the (His)6-alpha ·GroEL complex in either trans or cis configuration (31). About half of (His)6-alpha sequestered under GroES in cis was protected from PK digestion (Fig. 8A, lane 3). The proteolytically protected (His)6-alpha in the presence of GroES and ADP was able to refold with the added beta ·GroEL complex and Mg2+-ATP, resulting in 42% of the control E1 activity (Fig. 8B). The data depict equal probabilities for GroEL to form cis and trans complexes with GroES and a small polypeptide. When GroES, 10 mM ATP, and PK were present, the (His)6-alpha ·GroEL complex underwent multiple rounds of polypeptide release and rebinding (40, 41). The dynamic alternations between cis and trans configuration eventually led to digestion of most of the (His)6-alpha polypeptide through binding to GroEL in trans (Fig. 8A, lane 4). This result was supported by the absence of reconstituted E1 activity when the digested mixture was incubated with beta ·GroEL and Mg2+-ATP (Fig. 8B, lane 4).


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 8.   Capping of (His)6-alpha ·GroEL complex by GroES in cis. The (His)6-alpha ·GroEL complex (molar ratio 1:1) (2.3 µM) was incubated with GroES (4.6 µM) in the absence of nucleotides (lane 2) or in the presence of 10 mM ADP (lane 3) or 10 mM ATP (lane 4). Except lane 1, the complex mixtures were treated with 4 µg/ml PK for 15 min at 22 °C and the digestion quenched by the addition of 5 mM PMSF. A, one-half of the digests treated with PMSF were analyzed by SDS-PAGE, followed by Coomassie Blue staining. B, the other half of PMSF-quenched reaction mixtures was used to reconstitute E1 activity with a stoichiometric amount of the beta ·GroEL complex and 5 mM Mg2+-ATP. The recovery of E1 activity from the complex without PK treatment (lane 1) was expressed as 100%.

In a parallel experiment, the MBP-alpha ·GroEL complex was incubated with GroES in the presence or absence of nucleotides and subjected to PK digestion. E1 activity reconstituted with undigested MBP-alpha ·GroEL complex (lane 1) in the absence of nucleotides and PK (Fig. 9A, upper panel) and the beta ·GroEL complex was expressed as 100% (Fig. 9B, lane 1). In the absence of nucleotides but with (Fig. 9A, upper panel, lane 3) or without GroES (lane 2), MBP-alpha in the MBP-alpha ·GroEL complex was completely digested by PK, with the MBP moiety remaining intact. Similar results was obtained when the MBP-alpha ·GroEL complex was incubated with GroES and PK in the presence of ADP (lane 4) or ATP (lane 5). The complete digestion of MBP-alpha by PK was consistent with the absence of reconstituted E1 activity when the digested mixture was incubated with beta ·GroEL and Mg2+-ATP (Fig. 9B, lanes 3-5). The residual E1 activity (Fig. 9B, lanes 2-5) represented background of the radiochemical assay. The capping of GroEL by GroES was examined by loading a fraction of the digestion mixture on the gel as shown in the Fig. 9A (bottom panel). The C-terminal 16 amino acid residues of the GroEL ring not capped by GroES were digested by PK, resulting in smaller cut monomers without affecting the GroEL function (31). The 1:1 ratio of uncut and cut GroEL (lane 4) confirmed that GroEL·GroES formed the 1:1 asymmetric complex in the presence of ADP as established by x-ray crystallographic studies (30). These data, taken together, establish that the formation of cis MBP-alpha ·GroEL complex is sterically impossible, supporting the thesis that refolding of MBP-alpha is mediated exclusively through the trans configuration of the chaperonin complex.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 9.   Inability of GroES to cap MBP-alpha ·GroEL complex in cis. As a parallel experiment to Fig. 8, the MBP-alpha ·GroEL complex (molar ratio 1:1) (1.7 µM) was either untreated (lane 1) or digested with PK (4 µg/ml) in the presence of 3.4 µM GroES without added nucleotides (lane 3), with 10 mM ADP (lane 4) or with 10 mM ATP (lane 5). The MBP-alpha ·GroEL complex was also digested with PK in the absence of GroES (lane 2). A, untreated and PK-treated mixtures were separated by SDS-PAGE, followed by Coomassie Blue staining. The gel in the top panel was loaded with 45% of the incubation mixtures, and the gel in the bottom panel with 5% of the mixtures. B, the remainder of the incubation mixtures was incubated with a stoichiometric amount of the beta ·GroEL complex and 5 mM Mg2+-ATP to reconstitute E1 activity. The recovery of E1 activity from the MBP-alpha ·GroEL complex without the PK digestion (lane 1) was expressed as 100%.

GroES/Mg2+-ATP-dependent Release of MBP-alpha Monomers from the MBP-alpha ·GroEL Complex-- To determine whether GroES was involved in the folding of MBP-alpha , the release and folding of the fusion polypeptide from the MBP-alpha ·GroEL complex was studied. The MBP-alpha ·GroEL complex was incubated with Mg2+-ATP alone or Mg2+-ATP and GroES for different durations. After incubation, MBP-alpha monomers separated on a sucrose density gradient were quantified by SDS-PAGE and densitometric scanning. Fig. 10 shows that, in the presence of GroES and Mg2+-ATP, the MBP-alpha fusion is readily released from the MBP-alpha ·GroEL complex, and exists as soluble monomers. The level of the released monomers remains constant from 10 min to 2 h. In contrast, when the complex is incubated with Mg2+-ATP alone, the level of the discharged MBP-alpha monomers is less than 1/25 of that obtained when the complex is incubated with GroES and Mg2+-ATP for the same durations. The results indicate that GroES is required for the efficient release and folding of MBP-alpha monomers from the MBP-alpha ·GroEL complex.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 10.   Dependence on GroES for efficient release of MBP-alpha monomers from the MBP-alpha ·GroEL complex. The MBP-alpha ·GroEL complex (molar ratio 1:1) (60 µg) was incubated with 10 mM ATP in the presence (shaded bar) or absence (solid bar) of GroES for different lengths of time. After incubation, the mixtures were separated on a 10-25% sucrose density gradient, and fractions analyzed by SDS-PAGE and Coomassie Blue staining. The amount of MBP-alpha monomers (fractions 3-5) released from GroEL was quantified by densitometric scanning. The minimal density obtained from the 10-min incubation in the presence of Mg2+-ATP alone (solid bar) was treated as unity. The amounts of MBP-alpha monomers released in other samples were expressed as relative to the minimum.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Reconstitution of MBP-E1 with GroEL/GroES/Mg2+-ATP in vitro provides a novel system to study the question of differential domain folding in the presence of chaperonins. The kinetic data from this study indicate that the refolding of MBP-E1 begins with the proper local folding of MBP and alpha  moieties on the MBP-alpha chimeric polypeptide. This is ensued by the association of MBP-alpha (with the alpha  moiety folded) and beta  into a dimer, and subsequent dimerization of two (MBP-alpha )beta dimers into an (MBP-alpha )2beta 2 tetramer. The time course for reconstitution of E1 activity essentially superimposes with that for the formation of MBP-E1 tetramers, suggesting that the dimerization step is rate-limiting in the renaturation of E1. This result is similar to the refolding of (His)6-tagged E1 (14). The transition of dimers to tetramers as the rate-limiting step is also observed in homotetrameric proteins, e.g. bacterial phosphofructokinase (42) and lactate dehydrogenase, although their rates of folding are approximately 100-fold faster than that of E1 dimers. In the case of mitochondrial malic dehydrogenase, the rate constant for the association of two monomers into a native dimer is 3 × 104 M-1 s-1 (43), which is 2 orders of magnitude higher than that of E1 refolding with rate constants of 376 M-1 s-1 for MBP-E1 and 465 M-1 s-1 for untagged E1. Moreover, malate dehydrogenase can refold at the same rate either in the presence or absence of GroEL/GroES, although the yield of spontaneous refolding is only 15%, which is considerably lower than that of GroEL/GroES-dependent folding (80-90%) of the same enzyme (43). In contrast, the folding of E1 has an absolute requirement for the presence of GroEL/GroES/Mg2+-ATP, and an excess molar ratio (GroEL:E1 monomer) of GroEL is necessary to achieve the maximal degree of refolding (14).

MBP has been shown to function as a chaperone, similar to Hsp70 proteins, in assisting the refolding of citrate synthase. In the presence of DnaK (the bacterial homologue of Hsp70) or MBP, 22 and 13%, respectively, of refolding for citrate synthase can be achieved (44). Although less efficient than GroEL and GroES as chaperones (45), MBP or Hsp70 may help the refolding of citrate synthase by sequestering hydrophobic surfaces on the unfolded polypeptide. These results imply that the periplasmic MBP may interact with unfolded proteins in that compartment, resulting in an increase in productive folding. In the present study, fusion of MBP moiety to the alpha  sequence does not promote folding of the MBP-E1 proteins. In the MBP-alpha fusion, the rate constant for refolding of the MBP moiety (1.1 × 10-3 s-1) is 20-fold slower than that measured with unfused MBP (0.020 s-1), suggesting that there is intramolecular interference between MBP and alpha  sequences during refolding of the fusion polypeptide. This observation is similar to the folding kinetics of individual domains during the spontaneous folding of multidomain proteins. The refolding of an individual domain is usually more rapid than when it occurs in a multidomain protein (21-25). The intermolecular interference in folding is of functional significance during protein transport. For example, the precursors of MBP (18) and ribulose-binding protein (46), the presence of leader sequences at N termini of these proteins reduces the rate of folding by 30-40-fold in comparison with their mature forms. It is proposed that the targeting sequence of some exported proteins could behave as an inhibitor of folding. The retarded folding of an exporting protein allows a sufficient time for the partially folded precursor to be transported to a correct target site in the cell with the help of Hsp70 (46). On the other hand, negative interactions between concurrently folding domains may result in intramolecular misfolding. As a case in point, only 10% of total Ras-dihydrofolate reductase was in the soluble native form when expressed in E. coli (26). It has been suggested that co-translational domain folding has evolved in eukaryotic cytosol to mitigate the adverse intramolecular interference during the folding of large multidomain polypeptides (26). However, this mechanism is not relevant to bacterial or mitochondrial proteins which fold post-translationally or after import and processing (11-13).

Molecular chaperones may play the role of an unfoldase by reversing the off-pathway or that of a foldase by decreasing the activation energy of a folding intermediate along the folding pathway, and this results in an increase in the yield and/or rate of a folding reaction (6, 47-49). The similar rates for refolding of the MBP moiety on MBP-alpha in the absence and presence of GroEL/GroES indicate that GroEL and GroES do not act as a catalyst for MBP folding. It is noteworthy, however, the yield of MBP refolding in the present study increases from 25 to 30% in spontaneous refolding to 70-90% when assisted by GroEL/GroES. In contrast, folding of the alpha  moiety (rate constant, 2.95 × 10-4 s-1) absolutely requires the presence of GroEL/GroES, and is about 1 order of magnitude slower than folding of the MBP moiety (rate constant, 1.9 × 10-3 s-1) on MBP-alpha . The differential requirement for chaperonin-assisted folding remains unchanged for MBP and alpha  moieties either as individual proteins or in the form of a fusion polypeptide. Moreover, refolding of MBP-alpha as assisted by GroEL and GroES produces an intermediate, i.e. the MBP-alpha ·GroEL complex, in which part of the polypeptide chain, i.e. the MBP moiety, has already reached a native conformation which is resistant to PK and capable of binding to amylose resin, while the other segment of the chain, i.e. the alpha  moiety, is still unfolded and associated with GroEL. This binding topology is expected to also occur in mitochondria between Hsp60 and large mature polypeptides with different folding characteristics between domains, as a means to circumvent aggregation.

The interaction between GroEL and GroES in mediating the folding of large polypeptides such as MBP-alpha is unknown. Studies on chaperonin-assisted refolding of small polypeptides, e.g. ornithine transcarbamylase monomers (36 kDa), have shown that productive folding occurs exclusively through the cis complex, in which GroES and the unfolded polypeptide bind to the same ring of GroEL (31). However, this mechanism raises the question as to the size constraint for a polypeptide whose folding can be assisted by GroEL in a GroES-dependent manner. It has been speculated that GroES may play a role in promoting the productive release of large polypeptides from a trans configuration, that is, GroES and unfolded polypeptide bind to the opposite rings of GroEL (31). Here, PK digestion data provide evidence that the large MBP-alpha fusion polypeptide indeed binds to the asymmetric GroEL·GroES complex exclusively in trans (Fig. 9). One can argue that the MBP-alpha fusion forms a stable complex with GroEL but its folding is not assisted by GroES, similar to that observed with the large 124-kDa phytochrome photoreceptor (50) and the 72-kDa tail-spike protein of phage P22 (51). However, the level of MBP-alpha monomers released from the MBP-alpha ·GroEL complex with GroES and Mg2+ATP is sharply higher than that obtained with Mg2+-ATP alone (Fig. 10). Thus, our data strongly suggest that interactions between GroEL and GroES are needed for efficient folding of the MBP-alpha fusion. The availability of the stable MBP-alpha ·GroEL binary complex in vitro provides a system to investigate how GroES promotes the productive release of large polypeptides from GroEL.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grant DK-26758 and Welch Foundation Grant I-1286.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of a Welch Foundation predoctoral fellowship. This work was submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy from Southwestern Graduate School of Biomedical Sciences.

§ To whom correspondence should be addressed: Dept. of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-9038. Tel.: 214-648-2457; Fax: 214-648-8856; E-mail: chuang01{at}utsw.swmed.edu.

    ABBREVIATIONS

The abbreviations used are: Hsp, heat shock proteins; CDTA, trans-1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid; E1, branched-chain alpha -ketoacid decarboxylase; E2, dihydrolipoyl transacylase; E3, dihydrolipoyl dehydrogenase; MBP, maltose-binding protein; MBP-alpha , the fusion polypeptide between MBP and the alpha  subunit of E1; Ni-NTA, Ni-nitrilotriacetic acid; PK, proteinase K; PMSF, phenylmethylsulfonyl fluoride; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Ellis, R. J. (1991) Annu. Rev. Biochem. 60, 321-347[CrossRef][Medline] [Order article via Infotrieve]
  2. Bukau, B., and Horwich, A. L. (1998) Cell 92, 351-366[Medline] [Order article via Infotrieve]
  3. Hartl, F. U. (1996) Nature 381, 571-580[CrossRef][Medline] [Order article via Infotrieve]
  4. Ellis, J. (1992) Nature 358, 191-192[Medline] [Order article via Infotrieve]
  5. Kim, S., Willison, K. R., and Horwich, A. L. (1994) Trends Biochem. Sci. 19, 543-548[CrossRef][Medline] [Order article via Infotrieve]
  6. Ostermann, J., Horwich, A. L., Neupert, W., and Hartl, F. U. (1989) Nature 341, 125-130[CrossRef][Medline] [Order article via Infotrieve]
  7. Hemmingsen, S. M., Woolford, C., van der Vies, S. M., Tilly, K., Dennis, D. T., Georgopoulous, C. P., Hendrix, R. W., and Ellis, R. J. (1988) Nature 333, 330-334[CrossRef][Medline] [Order article via Infotrieve]
  8. Waldinger, D. C., Eckerskorn, C., Lottspeich, F., and Cleve, H. (1988) Biol. Chem. Hoppe-Seyler 369, 1185-1189[Medline] [Order article via Infotrieve]
  9. Hartman, D. J., Hoogenraad, N. J., Condron, R., and Hoj, P. B. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 3394-3398[Abstract]
  10. Legname, G., Fossati, G., Gromo, G., Monzini, N., Marcucci, F., and Modena, D. (1995) FEBS Lett. 361, 211-214[CrossRef][Medline] [Order article via Infotrieve]
  11. Stuart, R. A., Cyr, D. M., Craig, E. A., and Neupert, W. (1994) Trends Biochem. Sci. 19, 87-92[CrossRef][Medline] [Order article via Infotrieve]
  12. Schwarz, E., and Neupert, W. (1994) Biochim. Biophys. Acta 1187, 270-274[Medline] [Order article via Infotrieve]
  13. Hartl, F. U. (1991) Semin. Immunol. 3, 5-16[Medline] [Order article via Infotrieve]
  14. Chuang, J. L., Wynn, R. M., Song, J.-L., and Chuang, D. T. (1999) J. Biol. Chem. 274, 10395-10404[Abstract/Free Full Text]
  15. Wynn, R. M., Davie, J. R., Wang, Z., Cox, R. P., and Chuang, D. T. (1994) Biochemistry 33, 8962-8968[Medline] [Order article via Infotrieve]
  16. Wynn, R. M., Davie, J. R., Cox, R. P., and Chuang, D. T. (1992) J. Biol. Chem. 267, 12400-12403[Abstract/Free Full Text]
  17. Yeaman, S. J. (1989) Biochem. J. 257, 625-632[Medline] [Order article via Infotrieve]
  18. Chun, S.-Y., Strobel, S., Bassford, P. J., Jr., and Randall, L. L. (1993) J. Biol. Chem. 268, 20855-20862[Abstract/Free Full Text]
  19. Davie, J. R., Wynn, R. M., Cox, R. P., and Chuang, D. T. (1992) J. Biol. Chem. 267, 16601-16606[Abstract/Free Full Text]
  20. Wetlaufer, D. B. (1973) Proc. Natl. Acad. Sci. U. S. A. 70, 697-701[Abstract]
  21. Blond, S., and Goldberg, M. E. (1986) Proteins 1, 247-255[Medline] [Order article via Infotrieve]
  22. Blond-Elguindi, S., and Goldberg, M. E. (1990) Biochemistry 29, 2409-2417[Medline] [Order article via Infotrieve]
  23. Frieden, C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4413-4416[Abstract]
  24. Garel, J.-R., and Dautry-Varsat, A. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 3379-3383[Abstract]
  25. Dautry-Varsat, A., and Garel, J.-R. (1981) Biochemistry 20, 1396-1401[Medline] [Order article via Infotrieve]
  26. Netzer, W. J., and Hartl, F. U. (1997) Nature 388, 343-349[CrossRef][Medline] [Order article via Infotrieve]
  27. Anfinsen, C. B. (1973) Science 181, 223-230[Medline] [Order article via Infotrieve]
  28. Braig, K., Otwinowski, Z., Hegde, R., Boisvert, D. C., Joachimiak, A., Horwich, A. L., and Sigler, P. B. (1994) Nature 371, 578-586[CrossRef][Medline] [Order article via Infotrieve]
  29. Chen, S., Roseman, A. M., Hunter, A. S., Wood, S. P., Burston, S. G., Ranson, N. A., Clarke, A. R., and Saibil, H. R. (1994) Nature 371, 261-264[CrossRef][Medline] [Order article via Infotrieve]
  30. Xu, Z., Horwich, A. L., and Sigler, P. B. (1997) Nature 388, 741-750[CrossRef][Medline] [Order article via Infotrieve]
  31. Weissman, J. S., Hohl, C. M., Kovalenko, O., Kashi, Y., Chen, S., Braig, K., Saibil, H. R., Fenton, W. A., and Horwich, A. L. (1995) Cell 83, 577-587[Medline] [Order article via Infotrieve]
  32. Goloubinoff, P., Gatenby, A. A., and Lorimer, G. H. (1989) Nature 337, 44-47[CrossRef][Medline] [Order article via Infotrieve]
  33. Wynn, R. M., Davie, J. R., Chuang, J. L., Cote, C. D., and Chuang, D. T. (1998) J. Biol. Chem. 273, 13110-13118[Abstract/Free Full Text]
  34. Ferenci, T., and Klotz, U. (1978) FEBS Lett. 94, 213-217[CrossRef][Medline] [Order article via Infotrieve]
  35. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  36. Voet, D., and Voet, J. G. (1990) Biochemistry, Wiley, New York
  37. Sinclair, J. F., Ziegler, M. M., and Baldwin, T. O. (1994) Nat. Struct. Biol. 1, 320-326[Medline] [Order article via Infotrieve]
  38. Mendoza, J. A., Demeler, B., and Horowitz, P. M. (1994) J. Biol. Chem. 269, 2447-2451[Abstract/Free Full Text]
  39. Sparrer, H., Lilie, H., and Buchner, J. (1996) J. Mol. Biol. 258, 74-87[CrossRef][Medline] [Order article via Infotrieve]
  40. Martin, J., Mayhew, M., Langer, T., and Hartl, F. U. (1993) Nature 366, 228- 233[CrossRef][Medline] [Order article via Infotrieve]
  41. Weissman, J. S., Kashi, Y., Fenton, W. A., and Horwich, A. L. (1994) Cell 78, 693-702[Medline] [Order article via Infotrieve]
  42. Deville-Bonne, D., Bras, G. L., Teschner, W., and Garel, J.-R. (1989) Biochemistry 28, 1917-1922[Medline] [Order article via Infotrieve]
  43. Jaenicke, R., Rudolph, R., and Heider, I. (1979) Biochemistry 18, 1217-1223[Medline] [Order article via Infotrieve]
  44. Richarme, G., and Caldas, T. D. (1997) J. Biol. Chem. 272, 15607-15612[Abstract/Free Full Text]
  45. Zhi, W., Landry, S. J., Gierasch, L. M., and Srere, P. A. (1992) Protein Sci. 1, 522-529[Abstract/Free Full Text]
  46. Park, S., Liu, G., Toppoing, T. B., Cover, W. H., and Randall, L. L. (1988) Science 239, 1033-1035[Medline] [Order article via Infotrieve]
  47. Rothman, J. E. (1989) Cell 59, 591-601[Medline] [Order article via Infotrieve]
  48. Martin, J., Langer, T., Boteva, R., Schramel, A., Horwich, A. L., and Hartl, F. U. (1991) Nature 352, 36-42[CrossRef][Medline] [Order article via Infotrieve]
  49. Flynn, G. C., Chappell, T. G., and Rothman, J. E. (1989) Science 245, 385-390[Medline] [Order article via Infotrieve]
  50. Grimm, R., Donaldson, G. K., van der Vies, S. M., Schafer, E., and Gatenby, A. A. (1993) J. Biol. Chem. 268, 5220-5226[Abstract/Free Full Text]
  51. Gordon, C. L., Sather, S. K., Casjens, S., and King, J. (1994) J. Biol. Chem. 269, 27941-27951[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.